Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Athena Gogali"'
Autor:
Argyris Tzouvelekis, Christos Kyriakopoulos, Irini Gerogianni, Aggeliki Rapti, Vasileios Michailidis, Andreas Dimoulis, Despina Papakosta, Paschalis Steiropoulos, Panagiota Styliara, Konstantinos Kostikas, Athena Gogali
Publikováno v:
COPD, Vol 21, Iss 1 (2024)
Background There is limited data on the reasons for escalation or de-escalation of COPD inhaled therapies in routine clinical practice, especially after the follow-up pharmacological treatment guidance on the 2019 GOLD report and the 2020 ERS guideli
Externí odkaz:
https://doaj.org/article/50c524e3ce0f4aeabbad1f10cf545107
Publikováno v:
COPD, Vol 21, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/17071dcf105d4124973e116085704011
Autor:
Konstantinos P. Exarchos, Georgios Hillas, Paschalis Steiropoulos, Polyanthi Papanastasiou, Athena Gogali, Konstantinos Kostikas
Publikováno v:
The Clinical Respiratory Journal, Vol 18, Iss 7, Pp n/a-n/a (2024)
ABSTRACT Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous progressive lung condition characterized by long‐term respiratory symptoms and airflow limitation. Appropriate bronchodilation is the cornerstone of COPD treatment,
Externí odkaz:
https://doaj.org/article/0a7f178744824da5930a703e37258f72
Publikováno v:
European Respiratory Review, Vol 33, Iss 172 (2024)
Background: Six biologic agents are now approved for patients with severe asthma. This meta-analysis aimed to assess the efficacy and safety of licensed biologic agents in patients with severe asthma, including the recently approved tezepelumab. Meth
Externí odkaz:
https://doaj.org/article/8178616312bf4474943bd11439a35e00
Autor:
Konstantinos P. Exarchos, Nikoletta Rovina, George Krommidas, Dimitrios Latsios, Athena Gogali, Konstantinos Kostikas
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Asthma is a chronic inflammatory disease of the airways that causes recurring episodes of wheezing, breathlessness, chest tightness and coughing. Inhaled drugs on a daily basis are the cornerstone of asthma treatment, therefore, p
Externí odkaz:
https://doaj.org/article/a8a91b3aae4943979808bcbb799ae8c3
Autor:
Nikolaos Koulouris, Katerina Dimakou, Konstantinos Gourgoulianis, Nikolaos Tzanakis, Aggeliki Rapti, Mina Gaga, Niki Georgatou, Paschalis Steiropoulos, Christos Karachristos, Athena Gogali, Konstantinos Kalafatakis, Konstantinos Kostikas
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide accompanied by a substantial social and economic burden for the patient and the society. Poor sleep quality among COPD patients is frequentl
Externí odkaz:
https://doaj.org/article/ef3a0044756540cea95185c315d40c88
Publikováno v:
Barcelona Respiratory Network Reviews, Vol 9, Iss 1 (2023)
The management of chronic obstructive pulmonary disease (COPD) has changed significantly in this century, the most important element being the introduction of long-acting bronchodilators (LABD) as the basis of the treatment of patients with symptomat
Externí odkaz:
https://doaj.org/article/b6b38cf9bfa6462bb4ed2f62624cf954
Autor:
Antonia Assioura, Georgia Gkrepi, Konstantinos Exarchos, Konstantinos Kostikas, Athena Gogali, Christos Kyriakopoulos
Publikováno v:
Breathe, Vol 18, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/84a8360421db4b11a5c9606329e1283f
Publikováno v:
Diagnostics, Vol 13, Iss 13, p 2303 (2023)
Interstitial lung diseases (ILDs) comprise a rather heterogeneous group of diseases varying in pathophysiology, presentation, epidemiology, diagnosis, treatment and prognosis. Even though they have been recognized for several years, there are still a
Externí odkaz:
https://doaj.org/article/5750bdf721434ffd94fcdc2df11c5ee9
Autor:
Paraskevi Kirgou, Sotirios I. Sinis, Ilias E. Dimeas, Ilias C. Papanikolaou, Konstantinos Tatsis, Athena Gogali, Konstantinos I. Gourgoulianis, Dimitrios P. Bogdanos, Zoe Daniil
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Patients with idiopathic pulmonary fibrosis are screened for circulating autoantibodies as part of the initial interstitial lung disease workup. Management of seropositive idiopathic pulmonary fibrosis is currently considered no different than that o
Externí odkaz:
https://doaj.org/article/33b610d8712e4b32ba422992bfbbc95c